The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management
Cancers · 18.07.2024 · 16 (14) · 2580
DOI: 10.3390/cancers16142580 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 18.07.2024. Verfasst von Andrea Amaroli und 5 weiteren Autor:innen. Beteiligte Einrichtung: BIO-Photonics Overarching Research Laboratory (BIOPHOR), Department of Earth, Environmental and Life Sciences (DISTAV), University of Genoa, 16132 Ge…. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 278 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo per la Ricerca di Ateneo (FRA) University of Genoa, AIRC.
Abstract (Originalsprache)
Curcumin, a polyphenolic compound derived from Curcuma longa, exhibits significant therapeutic potential in cancer management. This review explores curcumin’s mechanisms of action, the challenges related to its bioavailability, and its enhancement through modern technology and approaches. Curcumin demonstrates strong antioxidant and anti-inflammatory properties, contributing to its ability to neutralize free radicals and inhibit inflammatory mediators. Its anticancer effects are mediated by inducing apoptosis, inhibiting cell proliferation, and interfering with tumor growth pathways in various colon, pancreatic, and breast cancers. However, its clinical application is limited by its poor bioavailability due to its rapid metabolism and low absorption. Novel delivery systems, such as curcumin-loaded hydrogels and nanoparticles, have shown promise in improving curcumin bioavailability and therapeutic efficacy. Additionally, photodynamic therapy has emerged as a complementary approach, where light exposure enhances curcumin’s anticancer effects by modulating molecular pathways crucial for tumor cell growth and survival. Studies highlight that combining low concentrations of curcumin with visible light irradiation significantly boosts its antitumor efficacy compared to curcumin alone. The interaction of curcumin with cytochromes or drug transporters may play a crucial role in altering the pharmacokinetics of conventional medications, which necessitates careful consideration in clinical settings. Future research should focus on optimizing delivery mechanisms and understanding curcumin’s pharmacokinetics to fully harness its therapeutic potential in cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BIO-Photonics Overarching Research Laboratory (BIOPHOR), Department of Earth, Environmental and Life Sciences (DISTAV), University of Genoa, 16132 Genoa, Italy.
- Department of Pharmacy (DIFAR), University of Genoa, 16132 Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
- Department of Experimental Medicine (DIMES), University of Genoa, 16132 Genoa, Italy.
ORCID-Profile: Andrea Amaroli, Isabella Panfoli, Matteo Bozzo, Sara Ferrando, Simona Candiani, Silvia Ravera
Förderung
- Fondo per la Ricerca di Ateneo (FRA) University of Genoa
- AIRC
Zitieren
APA
Amaroli, A., Panfoli, I., Bozzo, M., Ferrando, S., Candiani, S., & Ravera, S. (2024). The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management. Cancers, 16(14), 2580. https://doi.org/10.3390/cancers16142580
Vancouver
Amaroli A, Panfoli I, Bozzo M, Ferrando S, Candiani S, Ravera S. The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management. Cancers. 2024;16(14):2580. doi:10.3390/cancers16142580
BibTeX
@article{Amaroli2024,
author = {Amaroli, Andrea and Panfoli, Isabella and Bozzo, Matteo and Ferrando, Sara and Candiani, Simona and Ravera, Silvia},
title = {The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management},
journal = {Cancers},
year = {2024},
volume = {16},
number = {14},
pages = {2580},
doi = {10.3390/cancers16142580}
}
EUVIMED